ALICE CHOI: Open Payments
NPI 1861852717 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,794 in 120 payments from 16 companies in 2025. Trend: 2023 $1,113 · 2024 $2,077 · 2025 $2,794
Food & beverage: $2,794
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $866 |
| Janssen Biotech, Inc. | 18 | $463 |
| Aimmune Therapeutics, Inc. | 8 | $238 |
| Lilly USA, LLC | 12 | $231 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $198 |
| Madrigal Pharmaceuticals | 6 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $173 |
| Ardelyx, Inc. | 7 | $153 |
| Intercept Pharmaceuticals, Inc. | 4 | $87 |
| Braintree Laboratories, Inc. | 2 | $53 |
Products named: RINVOQ, TREMFYA, OMVOH, ZENPEP, REZDIFFRA, ENTYVIO, XIFAXAN, SKYRIZI.
Industry payments across CA — which companies pay providers there.
